Related Experiment Videos
Non-Hodgkin's lymphoma: present status and future prospects
1Department of Internal Medicine, Mayo Medical School, Rochester, Minn., USA.
Hospital Practice (1995)
|December 28, 1999
Summary
Non-Hodgkin
Area of Science:
- Oncology
- Hematology
Background:
- Non-Hodgkin's lymphoma encompasses diverse subtypes with varied clinical courses.
- Prognosis and treatment strategies are subtype-dependent.
Observation:
- Prognosis in large-cell lymphoma is influenced by patient age and other risk factors.
- Chemotherapy combined with autologous bone marrow transplantation can be effective for relapsed disease.
Findings:
- Novel antibody therapies targeting tumor cells are emerging.
- The precise role and efficacy of antibody-based treatments require further investigation.
Implications:
- Tailored management approaches are crucial for different non-Hodgkin's lymphoma subtypes.
- Further research is needed to define the optimal use of antibody therapies in lymphoma treatment.